Skip to content
Clinical Trials – home

Oxycodone Hydrochloride: A Comprehensive Guide for Patients

6 / 7
trials open to patients / all trials
6+
Countries

In short

This article examines the use of oxycodone hydrochloride, a powerful opioid pain medication, in various clinical trials. These studies aim to evaluate the drug's effectiveness, safety profile, and potential applications in different medical contexts, from post-surgical pain management to reformulated versions for improved bioavailability. Understanding these trials is crucial for advancing pain management strategies and ensuring patient safety.

At a glance

Study Types
Bioequivalence studies, pediatric analgesia trials, ICU pain management, pharmacokinetic evaluations
Patient Populations
Healthy adults, children (ages 1-6), ICU patients on mechanical ventilation
Key Outcomes Measured
Pain scores, emergence agitation, plasma drug concentrations, adverse events, extubation success rates
Formulations Studied
Immediate-release tablets, extended-release tablets, intravenous infusions
Dosage Ranges
5 mg to 80 mg for oral formulations; 0.03-0.2 mg/kg/h for intravenous infusions
Comparison Drugs
Remifentanil, original OxyContin formulations
Safety Monitoring
Vital signs, adverse events, gastrointestinal function, respiratory depression

What is Oxycodone Hydrochloride?

Oxycodone hydrochloride, often simply called oxycodone, is a powerful pain medication that belongs to a class of drugs known as opioids. It is a semi-synthetic opioid, which means it is partially derived from natural sources and partially created in a laboratory. Oxycodone is designed to provide effective relief for moderate to severe pain, both from cancer-related causes and other conditions.

Medical Uses

Oxycodone hydrochloride is primarily used to treat various types of pain, including:

  • Moderate to severe pain: This can include pain from injuries, surgeries, or chronic conditions.
  • Cancer-related pain: Oxycodone is often used to manage pain in cancer patients.
  • Osteoarthritis pain: Some studies have explored the use of oxycodone for pain relief in patients with osteoarthritis, a condition that causes joint pain and stiffness.
  • Post-operative pain: Research is being conducted on the use of oxycodone for pain management after surgery, including in intensive care units (ICUs).

How is it Administered?

Oxycodone hydrochloride can be administered in several ways, depending on the specific formulation and the patient's needs:

  • Oral tablets: Oxycodone is commonly available as oral tablets in various strengths, such as 5 mg, 10 mg, and 80 mg.
  • Extended-release formulations: Some versions of oxycodone are designed to release the medication slowly over time, providing longer-lasting pain relief.
  • Intravenous (IV) injection: In hospital settings, particularly in ICUs, oxycodone may be administered through an IV for more rapid pain relief.

The dosage and frequency of administration can vary widely depending on the individual patient's needs, the severity of pain, and other factors. It's crucial to take oxycodone exactly as prescribed by your healthcare provider.

Effectiveness

Oxycodone hydrochloride has been shown to be effective in managing various types of pain. Some key points about its effectiveness include:

  • Rapid onset: When administered intravenously, oxycodone can provide quick pain relief, with effects starting within minutes.
  • Long-lasting relief: Extended-release formulations can provide pain relief for extended periods, reducing the need for frequent dosing.
  • Comparable to other pain medications: Studies have shown that oral oxycodone can provide pain relief comparable to ibuprofen for children after fractures.
  • Effective for post-operative pain: Research suggests that oxycodone can be effective in managing pain after surgery, including in pediatric patients.

Side Effects and Safety

While oxycodone can be effective for pain management, it's important to be aware of potential side effects and safety considerations:

  • Common side effects: These may include nausea, vomiting, constipation, drowsiness, and dizziness.
  • Respiratory effects: Oxycodone can affect breathing, particularly at higher doses. However, some studies suggest it may have less impact on respiratory function compared to other opioids.
  • Gastrointestinal effects: Constipation is a common side effect of opioids like oxycodone. Some formulations combine oxycodone with an opioid antagonist to help prevent constipation.
  • Risk of dependence: As with all opioids, there is a risk of developing dependence or addiction with long-term use of oxycodone.

It's crucial to use oxycodone only as prescribed and to discuss any concerns or side effects with your healthcare provider.

Ongoing Research

Researchers continue to study oxycodone hydrochloride to better understand its effects and potential uses. Some areas of ongoing research include:

  • Pediatric use: Studies are investigating the safety and efficacy of oxycodone in children, particularly for post-operative pain management.
  • Comparison with other pain medications: Researchers are comparing oxycodone to other pain medications to determine its relative effectiveness and safety profile.
  • Use in intensive care: Studies are exploring the use of oxycodone for long-term pain management in ICU patients on mechanical ventilation.
  • Formulation improvements: Research is ongoing to develop new formulations of oxycodone that may offer improved safety or efficacy.

These ongoing studies aim to provide more information about the optimal use of oxycodone hydrochloride in various clinical settings and patient populations.

Questions people often ask

Conditions where Oxycodone Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Oxycodone Hydrochloride

Recruiting trials first

See all 7 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).